WELCOME TO
Inspira Health
"Improving Healthcare Through Clinical Audit"
Inspira Health is an innovative, award winning healthcare service provider which was established in 2010
Inspira Health works in partnership with NHS providers, NHS commissioners and industry partners to provide seamless, high quality, integrated care pathways for patients which are precisely tailored to their individual needs.
Primary Care Atrial Fibrillation Service
Inspira Health's award-winning Primary Care Atrial Fibrillation (PCAF) service provides specialists within GP practice to provide face-to-face clinical reviews with patients with a diagnosis of Atrial Fibrillation (AF).
Key results so far:
- Over 500 practices nationwide with 4.5 million population covered
- Over 20,000 Consultant reviews
- Prevented over 800 strokes and 480 premature deaths
Primary Care Secondary Prevention Service
The Primary Care Secondary Prevention Service is a Consultant Cardiologist-led Cardiovascular service to help achieve QOF and NICE guidelines and improve Patient Outcomes.
Why PCSP?
The NHS Long-term Plan identifies improving the management of cardiovascular disease (CVD) as a top priority. CVD is one of the main causes of death and disability in the UK. Lifestyle changes such as change in diet, reduction in alcohol, cessation of smoking, daily exercise and weight loss may help reduce patients’ CVD risk. There are also a range of medications available to assist in reducing an individuals CVD risk. Ensuring patients are informed about their lifestyle choices and treatment options is an important part of reducing the risk of CVD events.
Primary Care Diabetic Nephropathy Service
The Primary Care Diabetic Nephropathy Service is a Specialist Nurse Practitioner-led service to help achieve QOF and NICE guidelines and improve Patient Outcomes.
Why PCDN?
- The management of diabetic nephropathy is a major clinical and societal issue because of its widespread prevalence, and massive health and financial burden;
- Patients with advanced diabetic nephropathy can have a poor prognosis in terms of kidney function and a high risk of atherosclerotic cardiovascular disease
- Sodium–glucose cotransporter 2 (SGLT2) inhibitors have been receiving a great deal of attention owing to their protective effects on the kidney and atherosclerotic cardiovascular disease;
- The first step in treating diabetic nephropathy is to treat and control diabetes and, if needed, high blood pressure (hypertension). With good management of blood sugar and hypertension, you can prevent or delay kidney dysfunction and other complications.
NHS Health Check
The NHS Health Check is a national risk assessment, awareness and management programme for those aged 40 to 74 living in England who do not have an existing vascular condition, and who are not currently being treated for certain risk factors. It is aimed at preventing heart disease, stroke, diabetes and kidney disease.
Inspira Health provide:
- Facilitation of patient identification of the selected patient cohort;
- Facilitation of NHS Health Checks appointment bookings;
- Clinical facilitation of NHS Health Checks;
- Collection of NHS Health Checks data and regular feedback of performance.
Primary Care Metabolic Surgery
This service is currently being piloted, more details to follow.